Evaluation of SS-31 as a Potential Strategy for Tendinopathy Treatment: An In Vitro Model.
Xueying ZhangYing ZhangMeng ZhangYusuke NakagawaCamila B CaballoHazel H SzetoXiang-Hua DengScott A RodeoPublished in: The American journal of sports medicine (2022)
Mitochondrial dysfunction appears to play a role in the development of tendinopathy, and SS-31, as a mitochondrial protective agent, may be a therapeutic agent in the treatment of tendinopathy.